Literature DB >> 25479632

Serum inflammatory factor and cytokines in AECOPD.

Tie-Gang Jia1, Jian-Qing Zhao2, Jian-Hua Liu1.   

Abstract

OBJECTIVE: To explore the serum levels of IL-32, MMP-9,PCT and CRP in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
METHODS: A total of 50 patients with AECOPD and 45 cases with acute asthma attack admitted from October 2013 to August 2014 were selected, and the serum levels of IL-32, MMP-9, PCT and CRP were determined and compaed by using Double antibody sandwich Enzyme linked immunosorbent assay, immunofluorescence double antibody sandwich assay and immunoturbidimetry assay.
RESULTS: Serum levels of IL-32, MMP-9, PCT and CRP were significantly higher in AECOPD group than acute asthma attack group (P<0.05). IL-32 and MMP-9 were negatively correlated with lung function. MMP-9 in AECOPD patients was increased more significantly.
CONCLUSIONS: Serum levels of IL-32 and MMP-9 were negatively correlated with lung function, and the worse the lung function is, the more significant the increase is.
Copyright © 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AECOPD; AHTMA; CRP; IL-32; MMP-9; PCT; PF; Serum

Year:  2014        PMID: 25479632     DOI: 10.1016/S1995-7645(14)60177-2

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  7 in total

1.  Effect of the emphysema subtypes of patients with chronic obstructive pulmonary disease on airway inflammation and COTE index.

Authors:  Zheng Liu; Fang Shi; Jun-Xia Liu; Chang-Lan Gao; Meng-Miao Pei; Jing Li; Pei-Xiu Li
Journal:  Exp Ther Med       Date:  2018-09-27       Impact factor: 2.447

2.  Circulating IL-32 and IL-33 levels in patients with asthma and COPD: a retrospective cross-sectional study.

Authors:  Min-Hye Kim; Jae-Woo Kwon; Jang-Hee Hahn; Minseo Kim; Hun Soo Chang; Jong Sook Park; Sang-Heon Cho; Choon-Sik Park
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

Review 3.  Immunodeficiency in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Sheling Xie; Kaifei Wang; Wei Zhang; Kun Xiao; Peng Yan; Yanqin Li; Wanxue He; Yuhan Zhang; Lixin Xie
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

4.  Xiaoqinglong Decoction Protects the Lungs of AECOPD Mice through the AMPK/mTOR Signaling Pathway.

Authors:  Qingsong Huang; Hongjing Yang; Chuantao Zhang; Jianying Wu; Wei Xiao; Zhu Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-04       Impact factor: 2.629

Review 5.  Interleukin-32: its role in asthma and potential as a therapeutic agent.

Authors:  Tong Xin; Mo Chen; Liwei Duan; Yanling Xu; Peng Gao
Journal:  Respir Res       Date:  2018-06-25

6.  Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats.

Authors:  Xiaofan Lu; Ya Li; Jiansheng Li; Haifeng Wang; Zhaohuan Wu; Hangjie Li; Yang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-01       Impact factor: 2.629

7.  Plasma Inflammatory Cytokine IL-4, IL-8, IL-10, and TNF-α Levels Correlate with Pulmonary Function in Patients with Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome.

Authors:  Ai-Xia Huang; Li-Wen Lu; Wen-Juan Liu; Mao Huang
Journal:  Med Sci Monit       Date:  2016-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.